_PRIVATE_LIMITED_355366.webp)
Life Line Remedies (India) Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 07-07-2024
- Paid Up Capital ₹ 0.40 M
as on 07-07-2024
- Company Age 25 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -19.46%
(FY 2023)
- Profit -1017.98%
(FY 2023)
- Ebitda -733.21%
(FY 2023)
- Net Worth -38.14%
(FY 2023)
- Total Assets 10.93%
(FY 2023)
About Life Line Remedies (India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.40 M, as per Ministry of Corporate Affairs (MCA) records.
Raj Kumar, Sunita Rani, and Prem Juneja serve as directors at the Company.
- CIN/LLPIN
U74899DL1999PTC101601
- Company No.
101601
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Sep 1999
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Paschim Vihar, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Life Line Remedies (India)?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raj Kumar  | Director | 17-Sep-1999 | Current |
| Sunita Rani | Director | 03-Aug-2020 | Current |
| Prem Juneja | Director | 17-Sep-1999 | Current |
Financial Performance of Life Line Remedies (India).
Life Line Remedies (India) Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 19.46% decrease. The company also saw a substantial fall in profitability, with a 1017.98% decrease in profit. The company's net worth observed a substantial decline by a decrease of 38.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Life Line Remedies (India)?
In 2023, Life Line Remedies (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Stafford Laboratories Private LimitedActive 25 years 7 monthsRaj Kumar and Sunita Rani are mutual person
Ersten Life Science Private LimitedActive 22 years 3 monthsRaj Kumar and Sunita Rani are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Life Line Remedies (India)?
Unlock and access historical data on people associated with Life Line Remedies (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Life Line Remedies (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Life Line Remedies (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
